1st Quarter - Report

MICHAEL BEST STRATEGIES LLC for SAREPTA THERAPEUTICS

Firm
Client
Income
$110,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Scientific innovation in healthcare including gene therapy, rare diseases including Duchenne muscular dystrophy

LobbyistCovered position, as disclosed
TAMI JACKSON BUCKNER —
NINIO FETALVO —
MEGAN SARA SHELINE —
BRITTAN SPECHT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Scientific innovation in healthcare including gene therapy, rare diseases including Duchenne muscular dystrophy

LobbyistCovered position, as disclosed
TAMI JACKSON BUCKNER —
NINIO FETALVO —
MEGAN SARA SHELINE —
BRITTAN SPECHT —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.